Conditions: Prostate Cancer
Keywords: Prostate cancer docetaxel MDV3100 enzalutamide Xtandi
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 23
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine the safety of MDV3100 given in combination with Docetaxel in men with advanced prostate cancer.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: MDV3100
Intervention descriptions: intervention 1: 4 x 40 mg capsules, orally, once per day

Protocol document: